Publicacións nas que colabora con Pablo Aguiar Fernández (6)
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
2021
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10
-
POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation
Oncogene, Vol. 40, Núm. 15, pp. 2725-2740
2020
-
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
2019
-
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model
International Journal of Pharmaceutics, Vol. 572
2018
-
Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model
International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342